For close to twenty years, Stuart Weisbrod and Jacob Gottlieb have been running separate funds. Currently, they are working under one roof. The two men are investors in the healthcare sector. They recognize each other since they worked together in Merlin Biomed Group. Mr. Stuart Weisbord co-founded Merlin in the year 1998.
This investment management company concentrated on healthcare. It focused on different portfolios in the pharmaceutical, medical device, biotechnology, and healthcare service sectors. Stuart Weisbrod has had a remarkable record in biotechnology and healthcare investments.
Weisbrod also held positions in different firms like the Merrill Lynch, Harpel Partners, Oracle partners, and Prudential-Bache securities. His necessary expertise and network in building a winning team are provided by his professional background.
The successful team includes the renowned investor Jacob Gottlieb who worked for Weisbrod as a portfolio manager in the year 2000. At the height of technology revolution, Gottlieb worked at Merlin firm. He helped the firm achieve returns of more than a hundred percent in the year 1999 and 2000.
The portfolio managers including Gottlieb were able to generate large returns successfully. This helped them large prominent clients like the major family offices, pension funds, endowments, and high net worth individuals. Regardless of great years of success, Merlin refunded the investors and closed in the year 2007.
Weisbrod then came up with an idea of creating another firm by the name of Iguana Healthcare partners. The organization operates on the same standards as Merlin. Iguana Healthcare Partners focuses primarily on public companies in the healthcare sector.
It focuses on areas like medical device, pharmaceutical, biotechnology, and healthcare information technology companies. After leaving Merlin, Gottlieb created his firm by the name Visium Asset management. The corporation expanded rapidly and hired a significant number of employees.
In the year 2016, three executives were accused of mismarking and insider training bringing the business to a sudden end. Maintaining his role as the Chief Executive Officer, Gottlieb went on with his work to refund the investors and winding up the company.
The healthcare industry is about to see great things and remarkable changes in healthcare investment opportunities. This will be brought about by the working together of two titans who have vast experience in the financial entrepreneurship.